期刊文献+

乳腺癌多线与一线内科解救治疗病例对照研究

A Case-control Study between Multi-line and First-line Internal Medicine of Rescue Therapy for Breast Cancer
下载PDF
导出
摘要 目的探讨乳腺癌治疗方案的全程合理有效实施方法。方法收集沈阳军区总医院2008年1月—2013年5月收治的乳腺癌中接受四线及四线以上内科解救治疗56例(多线组),同时随机抽取同时期接受一线解救治疗的56例为一线组,回顾性分析两组的临床资料。结果多线组与一线组比较,≥60岁、单纯化疗、化疗联合靶向治疗、淋巴结转移数、病理分级程度方面,差异均有统计学意义(P<0.05)。多线组在疾病自然进展、随意更换方案、擅自减少剂量方面,明显高于一线组(P<0.05)。结论对一般状况较好、预期生存较长,能从多种治疗方案中获益的乳腺癌患者,应该尽量高效、合理、有序的实施数量有限的治疗方案。 Objective To explore the reasonable and effective methods in treatment of breast cancer in the whole course of the disease. Methods During January 2008 and May 2013, 56 patients with breast cancer, who received four- line or more internal medicine of rescue therapy, were chosen as group A, and 56 random patients with breast cancer, who received first-line internal medicine of rescue therapy, were chosen as group B. Clinical data in the two groups was retro- spectively analyzed. Results The differences in patients were or over 60 years old, only chemotherapy, chemotherapy combined with targeted therapy, the number of lymph node metastasis and pathological grades in the two groups were sta- tistically significant (P 〈 0. 05). The degree of natural progression of the disease, freewill change of therapy methods and unauthorized dose reduction in group A were significantly higher than those in group B (P 〈 0.05). Conclusion Limit- ed number of treatment methods should be implemented efficiently, rationally and orderly in breast cancer patients, who have good condition in general, longer life expectance and may benefit from multiple therapic methods.
出处 《解放军医药杂志》 CAS 2014年第3期4-7,共4页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
基金 科技部十二五重大新药创制平台子课题(2012ZX09303016-002) 2012年辽宁省科技攻关计划课题(2012225019)
关键词 乳腺肿瘤 化学疗法 辅助 临床方案 Breast neoplasm Chemotherapy, adjuvant Clinical protocol
  • 相关文献

参考文献24

  • 1Jemal A, Bray F, Center M M, et al. Global cancer sta- tistics[ J]. CA Cancer J clin, 2011,61 (2) :69-90.
  • 2Bao P P, Lu W, Cui Y, et al. Ginseng and Ganoderma Iueidum use after breast cancer diagnosis and quality of life: a report form the Shanghai Breast Cancer Survival Study[ J]. PLoS-One, 2012,7(6) :39343.
  • 3Lee C K, Gebski V J, Coates A S, et al. Trade-offs in quality of life and survival with chemotherapy for ad- vanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cy- clophosphamide, methotrexate, 5-fluorouracil and predni- sone[ J]. Springerplus, 2013,2( 1 ) :391.
  • 4蔡君东,刘晶.醋酸甲羟孕酮联合化疗治疗转移性乳腺癌疗效观察[J].中国医药,2012,7(4):409-411. 被引量:7
  • 5Chopra I, Kamal K M. A systematic review of quality of life instruments in long-term breast cancer survivors [ J ]. Health Qual Life Outcomes, 2012,10(3) :14.
  • 6张立新,孙芳初,董桂兰,刘卫东.多西紫杉醇联合卡培他滨治疗蒽环类耐药的转移性乳腺癌近期疗效评价及相关因素[J].中国综合临床,2009,25(8):867-869. 被引量:6
  • 7魏少琳.多西他赛联合卡培他滨治疗转移性乳腺癌30例临床观察[J].中国煤炭工业医学杂志,2010,13(10):1524-1525. 被引量:4
  • 8Chung W S, Park M S, Shin S J. Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria [ J ]. Am J Roentgenol, 2012,199(4) :809-815.
  • 9李霓,郑荣寿,张思维,邹小农,曾红梅,代珍,陈万青.中国城乡女性乳腺癌发病趋势分析和预测[J].中华预防医学杂志,2012,46(8):703-707. 被引量:144
  • 10Colomiere M, Permezel M, Riley C, et al. Defecfive in- sulinSignaling in placenta from pregnancies complicated bygestationaldiabetes mellitus [ J ]. Eur J Endocfinol, 2009,160(4) :567-578.

二级参考文献97

共引文献273

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部